Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The role of propranolol in the treatment of infantile haemangioma

There has been a change in the management of infantile haemangioma with the introduction of propranolol. The aim of this study is to retrospectively evaluate a simple treatment for infantile haemangioma at the Red Cross War Memorial Children’s Hospital (RCWMCH) and document the results. While it i...

Full description

Saved in:
Bibliographic Details
Main Author: Moodley, Sean Thirumalay
Other Authors: Hudson, Donald
Format: Thesis
Language:English
Published: Division of Plastic and Reconstructive Surgery 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613235341950976
access_status_str Open Access
author Moodley, Sean Thirumalay
author2 Hudson, Donald
author_browse Hudson, Donald
Moodley, Sean Thirumalay
author_facet Hudson, Donald
Moodley, Sean Thirumalay
author_sort Moodley, Sean Thirumalay
collection Thesis
description There has been a change in the management of infantile haemangioma with the introduction of propranolol. The aim of this study is to retrospectively evaluate a simple treatment for infantile haemangioma at the Red Cross War Memorial Children’s Hospital (RCWMCH) and document the results. While it is known that all haemangiomas undergo involution at some stage, some haemangiomas pose certain problems. These relate mainly to visual axis obstruction and aesthetics. Subjects are children in the first two years of life presenting with haemangiomas. All patients were treated with oral propranolol in conjunction with haemangioma size documentation, using a simple radiological modality, i.e. ultrasound imaging. Patients are followed up and clinical and radiological evaluations are undertaken to observe changes in size and appearance. Propranolol is non-selective β-adrenergic antagonist that is used extensively for the treatment of a multitude of disorders, mainly cardiovascular indications. The main adverse effects include bradycardia, hypotension and bronchospasms. For the purposes of this study, all subjects were routinely examined, especially with regard to the cardiopulmonary systems. Any perceived anomaly was referred to the cardiorespiratory physicians at RCWMCH for further evaluation, which includes all the necessary investigations such as electrocardiograms(ECG) and echocardiograms. Therefore, only fit healthy patients were selected for this study. Patients are educated and fully informed regarding the adverse effect profile of propranolol, and advised of the appropriate route of management.
format Thesis
id oai:open.uct.ac.za:11427/13923
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:32:54.720Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2015
publishDateRange 2015
publishDateSort 2015
publisher Division of Plastic and Reconstructive Surgery
publisherStr Division of Plastic and Reconstructive Surgery
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/13923 The role of propranolol in the treatment of infantile haemangioma Moodley, Sean Thirumalay Hudson, Donald Plastic and Reconstructive Surgery There has been a change in the management of infantile haemangioma with the introduction of propranolol. The aim of this study is to retrospectively evaluate a simple treatment for infantile haemangioma at the Red Cross War Memorial Children’s Hospital (RCWMCH) and document the results. While it is known that all haemangiomas undergo involution at some stage, some haemangiomas pose certain problems. These relate mainly to visual axis obstruction and aesthetics. Subjects are children in the first two years of life presenting with haemangiomas. All patients were treated with oral propranolol in conjunction with haemangioma size documentation, using a simple radiological modality, i.e. ultrasound imaging. Patients are followed up and clinical and radiological evaluations are undertaken to observe changes in size and appearance. Propranolol is non-selective β-adrenergic antagonist that is used extensively for the treatment of a multitude of disorders, mainly cardiovascular indications. The main adverse effects include bradycardia, hypotension and bronchospasms. For the purposes of this study, all subjects were routinely examined, especially with regard to the cardiopulmonary systems. Any perceived anomaly was referred to the cardiorespiratory physicians at RCWMCH for further evaluation, which includes all the necessary investigations such as electrocardiograms(ECG) and echocardiograms. Therefore, only fit healthy patients were selected for this study. Patients are educated and fully informed regarding the adverse effect profile of propranolol, and advised of the appropriate route of management. 2015-09-15T10:06:09Z 2015-09-15T10:06:09Z 2013 Master Thesis Masters MMed http://hdl.handle.net/11427/13923 eng application/pdf Division of Plastic and Reconstructive Surgery Faculty of Health Sciences University of Cape Town
spellingShingle Plastic and Reconstructive Surgery
Moodley, Sean Thirumalay
The role of propranolol in the treatment of infantile haemangioma
thesis_degree_str Master's
title The role of propranolol in the treatment of infantile haemangioma
title_full The role of propranolol in the treatment of infantile haemangioma
title_fullStr The role of propranolol in the treatment of infantile haemangioma
title_full_unstemmed The role of propranolol in the treatment of infantile haemangioma
title_short The role of propranolol in the treatment of infantile haemangioma
title_sort role of propranolol in the treatment of infantile haemangioma
topic Plastic and Reconstructive Surgery
url http://hdl.handle.net/11427/13923
work_keys_str_mv AT moodleyseanthirumalay theroleofpropranololinthetreatmentofinfantilehaemangioma
AT moodleyseanthirumalay roleofpropranololinthetreatmentofinfantilehaemangioma